Division of Communication Sciences and Disorder

Medicine & Life Sciences

1. Coronavirus 100%
2. Pandemics 96%
3. Trisomy mosaic Chromosome 9 76%
4. benralizumab 72%
5. Laryngeal papillomatosis 65%
6. Otolaryngology 62%
7. Vocal Cords 60%
8. Laryngoplasty 60%
9. Practice Guidelines 52%
10. Tracheotomy 51%
11. Mosaicism 48%
12. Injections 45%
13. Telemedicine 44%
14. Trachea 41%
15. Quality Improvement 38%
16. Quality of Health Care 34%
17. Pathologic Constriction 31%
18. Muscle Hypertonia 31%
19. Ultrasonography 30%
20. Postoperative Complications 28%
21. Laryngeal Nerves 28%
22. Otolaryngologists 27%
23. Elderly 26%
24. Pediatrics 25%
25. Intubation 24%
26. Laryngoscopy 24%
27. Databases 23%
28. Botulinum Toxins 23%
29. Manuscripts 23%
30. Nerve Block 22%
31. Tracheostomy 22%
32. Global Health 20%
33. Therapeutics 20%
34. Karyotype 20%
35. Outpatients 19%
36. Cytogenetics 19%
37. Patient Care 18%
38. Respiration 16%
39. Interleukin-5 Receptors 16%
40. Anatomy 16%
41. Anesthesia 15%
42. Recurrent respiratory papillomatosis 15%
43. Asthma 15%
44. Neck 15%
45. Radiation 14%
46. Head 14%
47. Clinical Studies 13%
48. Respiratory Protective Devices 13%
49. Postoperative Period 12%
50. Quality of Life 12%
51. Guidelines 12%
52. Laryngoscopes 12%
53. Reoperation 12%
54. Delivery of Health Care 12%
55. Phenotype 11%
56. Equipment and Supplies 11%
57. Coronavirus Infections 11%
58. Preprints 11%
59. Personal Protective Equipment 11%
60. Nonparametric Statistics 10%
61. Larynx 10%
62. Wounds and Injuries 9%
63. Eosinophils 9%
64. Smoking 9%
65. Current Procedural Terminology 9%
66. Demography 8%
67. Odds Ratio 8%
68. Safety 8%
69. Mechanical Ventilators 8%
70. Retrospective Studies 8%
71. Tongue 8%
72. Dysphonia 7%
73. Asthenia 7%
74. Intensive Care Units 7%
75. Monoclonal Antibodies 7%
76. Disease Outbreaks 7%
77. Publications 6%
78. Information Storage and Retrieval 6%
79. Electronic Health Records 5%
80. MEDLINE 5%
81. Vocal Cord Paralysis 5%
82. Pathologists 5%
83. Chi-Square Distribution 5%
84. Consensus 5%
85. PubMed 5%
86. Growth 5%